CNS Pharmaceuticals CNSP
NASDAQ CNSP
$5.83 -0.17 (-2.83%)
As of: Aug 21, 2026 · 3:06 PM EDT

CNS Pharmaceuticals (CNSP) Other financing activities (2020 - 2025)

CNS Pharmaceuticals' (CNSP) quarterly Other financing activities came in at $844.0 in Q3 2025, down 69.67% on a QoQ basis from $2783.0 in Q2 2025.

CNS Pharmaceuticals (CNSP) Other financing activities (2020 - 2025) Analysis & Trends

CNS Pharmaceuticals (CNSP) has 6 years of Other financing activities data on file, last reported at $844.0 in Q3 2025.

  • Quarterly Other financing activities changed N/A year-over-year to $844.0 in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $3627.0 (down 82.99% YoY) and the FY2025 annual result came in at $3627.0, down 82.99% from the prior year.
  • Other financing activities retreated to $844.0 in Q3 2025, from $2783.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $2.2 million in Q4 2023 to a low of -$1.0 in Q4 2024.
  • A 5-year average of $301970.5 and a median of $2783.0 in 2025 frame the typical range for Other financing activities.
  • Annual changes were most pronounced in 2023 — Other financing activities soared 1894451.69% — and 2024, when it sank 100.0%.
  • Tracing CNSP's Other financing activities over 5 years: stood at $332750.0 in 2021, then plunged by 99.96% to $118.0 in 2022, then soared by 1894451.69% to $2.2 million in 2023, then sank by 100.0% to -$1.0 in 2024, then jumped by 84500.0% to $844.0 in 2025.
  • The last three Other financing activities figures came in at $844.0 (Q3 2025), $2783.0 (Q2 2025), and -$1.0 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 CNS Pharmaceuticals 2.65 Mn -4.55 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 844.00
Sep 30, 2025 844.00
Jun 30, 2025 2,783.00
Jun 30, 2025 2,783.00
Dec 31, 2024 -1.00
Dec 31, 2024 -1.00
Jun 30, 2024 8,921.00
Jun 30, 2024 8,921.00
Mar 31, 2024 12,405.00
Mar 31, 2024 12,405.00
Dec 31, 2023 2.24 Mn
Dec 31, 2023 2.24 Mn
Jun 30, 2023 725,059.00
Jun 30, 2023 725,059.00
Mar 31, 2023 609.00
Mar 31, 2023 609.00
Dec 31, 2022 118.00
Dec 31, 2022 118.00
Mar 31, 2022 2,616.00
Mar 31, 2022 2,616.00